News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Research>UBS Lowers PA GOODDOCTOR's TP to HKD14.5, Rating Neutral
PA GOODDOCTOR (01833.HK)'s 2025 revenue grew by 13.7% YoY to RMB5.47 billion, while net profit and non-IFRS net profit amounted to RMB378 million and RMB414 million, respective...
Reset
Send
The window will close in 5 seconds
<Research>UBS Lowers PA GOODDOCTOR's TP to HKD14.5, Rating Neutral
Close
Recommend
7
Positive
5
Negative
4
 
 

PA GOODDOCTOR (01833.HK)  +0.170 (+1.446%)    Short selling $73.21M; Ratio 38.470%   's 2025 revenue grew by 13.7% YoY to RMB5.47 billion, while net profit and non-IFRS net profit amounted to RMB378 million and RMB414 million, respectively, indicating YoY increases of 5.2 ppts and 4.3 ppts in net profit margin and adjusted net profit margin to 6.9% and 7.6%, according to a report from UBS.

UBS has raised its EPS forecast for PA GOODDOCTOR for each year from 2026 to 2028 to RMB0.22, RMB0.31, and RMB0.39. PA GOODDOCTOR's target price dropped from HKD16.5 to HKD14.5, with a Neutral rating.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-03-27 16:25.)

Related News Jefferies Upgrades Ping An Good Doctor (01833.HK) to 'Hold', Raises TP to HKD12.4

AAStocks Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.